Clinical research observations indicate that IL-1β and IL-1Ra levels rise together in the early subacute phase of stroke, implying that IL-1Ra upregulation serves as a compensatory response to IL-1–mediated inflammation rather than reflecting its complete suppression (Kotlega et al., 2025). The gene discussed is IL1B; the disease is stroke disorder.